Beneficial effects of low-toxicity regimens with MMF in renal recipients with late allograft dysfunction.
Folkmane
I
I
Department of Transplantation, Medical Academy of Latvia, Riga, Latvia. latgraft@latnet.lv
Bernarde
K
K
Bicans
J
J
Amerika
D
D
Rozentals
R
R
D000328:Adult; D016572:Cyclosporine / Q000627:therapeutic use*; D006084:Graft Rejection; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012086:Reoperation; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid